InsidersTradesSigma
Follow the Enorama Pharma AB stock price and the full insider trade history of the company, a listed issuer based in Finland. Shares are quoted on FI FI, under the oversight of FIN-FSA. Operating in the Health Care sector, Enorama Pharma AB has logged 1 public disclosures. Market capitalisation: €21.2m. The latest transaction was disclosed on 23 December 2025 (Other). Among the most active insiders: Ara Abrahamian. The full history is accessible without an account.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
1 of 1 declaration